ARI
RMD icon

Applied Research Investments’s ResMed RMD Stock Holding History

Applied Research Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,818
Closed -$683K – 34
2022
Q1 		$683K Sell
2,818
-9,234
-77% -$2.23M 2.04% 26
2021
Q4 		$3.14M Buy
12,052
+890
+8% +$231K 1.03% 35
2021
Q3 		$2.94M Sell
11,162
-457
-4% -$125K 0.98% 35
2021
Q2 		$2.86M Sell
11,619
-13,152
-53% -$2.76M 1.02% 35
2021
Q1 		$4.81M Buy
24,771
+1,185
+5% +$238K 1.75% 21
2020
Q4 		$5.01M Buy
23,586
+4,269
+22% +$851K 2.14% 17
2020
Q3 		$3.31M Buy
19,317
+5,478
+40% +$1.01M 1.87% 17
2020
Q2 		$2.66M Buy
+13,839
New +$2.26M 2.32% 18

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Applied Research Investments's RMD Position: Q2 2022 in Review

Applied Research Investments sold out of ResMed (RMD) in Q2 2022, closing a stake of 2,818 shares — an estimated $683K sold.

Applied Research Investments first reported a position in RMD in Q2 2020 and held it in 8 quarters. The position peaked at $5.01M in Q4 2020. 676 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

  • Applied Research Investments reported no remaining ResMed position as of Q2 2022 after selling out during the quarter.
  • Applied Research Investments sold 2,818 ResMed shares in Q2 2022, an estimated $683K.
  • Applied Research Investments first reported a position in ResMed in Q2 2020 and held it in 8 quarters.
  • Applied Research Investments's ResMed position peaked at $5.01M in Q4 2020.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on Applied Research Investments's 13F filing for Q2 2022, filed 2 Aug 2022.